studi
influenc
linker
rigid
chang
donoracceptor
properti
three
seri
nucleotid
analog
contain
pxhnc
residu
xch
oh
ch
ch
oh
ch
ch
ch
ch
oh
ch
replac
pch
ochrfrag
acycl
nucleosid
phosphon
eg
adefovir
cidofovir
synthes
edc
prove
provid
good
yield
analog
respect
nucleobasederiv
acet
acid
new
phosphorusnucleobas
linker
character
two
fragment
restrict
rotat
within
amid
bond
fouratom
unit
pch
oh
ch
n
pch
oh
ch
c
pch
ch
oh
c
antiperiplanar
disposit
p
nc
atom
deduc
h
c
nmr
spectral
data
synthes
analog
pxhnc
ch
b
xch
oh
ch
ch
oh
ch
ch
ch
ch
oh
ch
appear
inact
antivir
assay
wide
varieti
dna
rna
virus
concentr
two
phosphon
show
cytostat
activ
toward
myeloid
leukemia
multipl
myeloma
cell
ic
respect
graphic
abstract
cm
h
nmr
mhz
cd
od
hc
cbr
c
ch
poch
ch
ddd
j
hz
j
hz
j
hz
pch
ddd
j
hz
j
hz
j
hz
pccc
h
h
b
ddd
j
hz
j
hz
j
hz
pccch
h
b
ddddd
j
hz
j
hz
j
hz
j
hz
j
hz
pcch
h
b
ddddd
j
hz
j
hz
j
hz
j
hz
j
hz
pcch
h
b
j
hz
poch
ch
ppm
c
nmr
mhz
cd
od
j
hz
pc
j
hz
poc
j
hz
pccc
j
hz
pcc
ch
h
b
poch
ch
ddd
j
hz
j
hz
j
hz
pchch
ddd
j
hz
j
hz
j
hz
pcch
h
b
ddd
dt
j
hz
j
hz
j
hz
pcch
h
b
j
hz
hc
cch
j
hz
poch
ch
ppm
c
nmr
mhz
cd
od
j
hz
pc
j
hz
poc
j
hz
pcc
j
hz
pocc
ppm
p
nmr
mhz
cd
od
ppm
despit
numer
effort
highli
effect
antivir
drug
without
side
effect
yet
avail
search
compound
appear
even
difficult
sinc
variou
virus
undergo
fast
mutat
sever
antivir
medic
physician
dispos
among
acycl
nucleosid
phosphon
anp
belong
import
formul
deliv
adefovir
tenofovir
hmpa
cidofovir
fig
use
sever
decad
structur
framework
stimul
chemist
creat
modif
activ
linker
connect
nucleobas
phosphon
acid
moieti
seem
first
choic
modif
approach
far
lead
discoveri
activ
compound
base
commonli
accept
mechan
action
anp
structur
new
analog
contain
termini
p
ch
fragment
respons
stabil
toward
phosphatecleav
enzym
nucleobas
close
analog
facilit
interact
nucleobas
viral
nucleic
acid
prefer
fouratom
linker
capabl
hydrogen
bond
interconnect
unit
recent
put
forward
idea
replac
pch
ochrfrag
amid
bond
inspir
success
applic
isoster
replac
bond
methylen
ether
ch
moieti
studi
biolog
activ
natur
peptid
howev
introduct
amid
pch
hnc
residu
significantli
increas
donoracceptor
interact
within
new
linker
also
modifi
conform
flexibl
due
restrict
rotat
around
amid
bond
first
approach
four
seri
phosphon
amid
gener
formula
synthes
fig
paper
continu
effort
identifi
structur
featur
acycl
nucleosid
phosphon
contain
amid
bond
respons
antivir
activ
phosphon
contain
aliphat
linkag
x
ch
ch
ch
ch
ch
ch
ether
interconnect
ch
och
ch
includ
methylen
group
secur
separ
nitrogen
atom
nucleobas
phosphoru
atom
four
bond
result
compound
structur
closest
drug
appear
inact
henc
reason
instal
addit
polar
function
aliphat
linker
could
improv
acycl
nucleosideenzym
interact
thu
significantli
increas
activ
herein
wish
describ
studi
synthesi
biolog
activ
new
amid
hydroxi
group
within
aliphat
linker
synthes
final
acycl
nucleosid
phosphon
approach
involv
format
amid
bond
respect
acet
acid
deriv
follow
scheme
mani
year
biolog
activ
phosphon
nucleosid
analog
studi
employ
free
phosphon
acid
recent
administ
form
prodrug
ester
amid
significantli
improv
bioavail
polar
acid
opt
test
phosphon
diethyl
ester
sinc
extent
resembl
lipophil
prodrug
abil
permeabl
cell
membran
recent
experi
line
strategi
discov
exampl
biolog
activ
phosphon
diethyl
ester
substitut
variou
heterocycl
motiv
respect
free
acid
appear
inact
furthermor
afraid
possibl
dehydr
hydroxyalkylphosphon
harsh
condit
associ
applic
exampl
acid
base
even
iodotrimethylsilan
accomplish
synthesi
second
seri
amid
pure
effici
prepar
scheme
phosphon
known
compound
prepar
ammonolysi
diethyl
author
fail
provid
full
character
materi
obtain
phosphon
also
known
obtain
similar
manner
diethyl
though
author
unabl
prove
puriti
product
experi
framework
assur
us
phosphon
highest
puriti
could
obtain
epoxid
respect
dibenzylamin
appli
instead
ammonia
follow
hydrogenolysi
scheme
avail
synthet
strategi
phosphon
take
advantag
addit
diethyl
phosphit
deriv
nprotect
scheme
hand
ncbz
protect
follow
swern
oxid
prove
optim
prepar
aldehyd
later
subject
triethylaminecatalyz
phosphoryl
provid
protect
hydroxyphosphon
final
hydrogenolysi
gave
pure
phosphon
overal
yield
reagent
condit
bn
nh
h
b
h
pdc
etoh
h
known
benzouracilcontain
acet
acid
prepar
alkyl
respect
nucleobas
chloroor
bromoacet
acid
synthesi
amid
contain
cytosineand
adenineacetyl
subunit
requir
prior
protect
start
acid
ncbzand
ndibocderiv
significantli
increas
lipophil
final
product
follow
literatur
preced
later
confirm
experi
anticip
prepar
guanin
analog
fig
precursor
scheme
use
acet
acid
substrat
high
puriti
secur
turn
coupl
seri
nucleobaseacet
acid
scheme
establish
earlier
synthes
amid
best
perform
presenc
edc
hcl
coupl
reagent
scheme
give
product
high
puriti
good
yield
although
succeed
purif
phosphon
silica
gel
column
condit
homolog
obtain
insepar
mixtur
contain
variou
amount
triethylamin
hydrochlorid
hplc
techniqu
appli
case
partial
deprotect
occur
provid
pure
mononboc
protect
phosphon
fig
addit
mixtur
well
free
triethylamin
hydrochlorid
sever
attempt
transform
moieti
phosphon
guanin
phosphon
appear
fruitless
lead
complex
mixtur
unidentifi
product
also
interest
conform
mobil
amid
within
new
acycl
linker
provid
import
inform
regard
structureact
analysi
sinc
h
nmr
spectra
nucleotid
analog
exhibit
almost
ident
pattern
regard
pch
oh
ch
nhc
ch
fragment
conclud
methanol
solut
exist
conform
detail
analysi
h
nmr
spectrum
includ
h
p
one
clearli
reveal
antiperiplanar
disposit
phosphoryl
amid
group
project
fig
vicin
coupl
hz
hz
fit
well
rang
expect
gauch
antiperiplanar
arrang
proton
furthermor
valu
j
coupl
constant
close
hz
valu
well
correl
characterist
gauch
hydrogenphosphoru
relationship
stabil
conform
primarili
result
steric
bulki
substitu
may
also
enforc
h
hydrogen
bond
within
fivememb
ring
depict
fig
suggest
find
support
larg
downfield
shift
proton
ppm
compar
proton
ppm
observ
amid
co
act
deshield
group
possibl
h
hydrogen
bond
strong
enough
enabl
free
rotat
around
bond
also
h
nmr
spectra
nucleotid
analog
show
almost
ident
pattern
pch
oh
ch
ch
nhc
ch
chain
reason
methanol
adopt
conform
fig
resembl
term
antiperiplanar
locat
phosphoryl
h
group
h
h
p
c
nmr
spectra
follow
diagnost
coupl
constant
extract
j
hz
j
hz
j
hz
j
hz
j
hz
fulli
confirm
conclus
thu
steric
requir
diethoxyphosphoryl
group
h
substitu
respons
stabil
antiperiplanar
conform
howev
although
vicin
protonproton
coupl
success
calcul
h
h
b
h
b
subunit
valu
interpret
favor
free
rotat
around
bond
thu
preclud
intramolecular
hbond
amid
moieti
similar
h
nmr
spectra
nucleotid
analog
spectra
analog
methanol
display
similar
pattern
pch
ch
oh
ch
nhc
ch
portion
valu
j
hz
togeth
j
hz
j
hz
found
c
h
nmr
spectra
suggest
diethoxyphosphoryl
ch
nhc
group
steric
reason
prefer
exist
anti
conform
fig
commonli
observ
conclus
support
lack
vicin
coupl
expect
gauch
relationship
within
unit
free
rotat
within
ch
nhc
moieti
evid
valu
vicin
coupl
phosphon
ie
evalu
inhibitori
activ
wide
varieti
dna
rna
virus
use
follow
cellbas
assay
antivir
assay
perform
human
embryon
lung
ganciclovir
cidofovir
acyclovir
brivudin
zalcitabin
zanamivir
alovudin
amantadin
rimantadin
ribavirin
dextran
sulfat
molecular
weight
mycophenol
acid
urtica
dioica
agglutinin
uda
use
refer
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
viru
plaqu
format
vzv
reduc
virusinduc
cytopathogen
virus
none
test
compound
show
appreci
antivir
activ
toward
test
dna
rna
virus
concentr
affect
cell
morpholog
hel
hela
vero
mdcl
cell
cytostat
inhibitori
concentr
ic
caus
decreas
cell
prolifer
determin
phosphon
ie
toward
cancer
cell
line
pancreat
adenocarcinoma
chronic
myeloid
leukemia
colorect
carcinoma
lung
carcinoma
acut
lymphoblast
leukemia
acut
myeloid
leukemia
chronic
myeloid
leukemia
multipl
myeloma
nonhodgkin
lymphoma
well
normal
retina
non
cancer
cell
htert
docetaxel
stauroporin
use
refer
compound
among
screen
compound
phosphon
slightli
cytostat
multipl
myeloma
cell
ic
valu
respect
howev
lower
refer
drug
ic
valu
docetaxel
stauroporin
respect
hand
compound
show
notic
inhibitori
properti
toward
chronic
myeloid
leukemia
ic
howev
still
lower
docetaxel
ic
stauroporin
ic
test
compound
toxic
normal
noncancer
retina
cell
htert
concentr
studi
concept
replac
pch
ochrfrag
acycl
nucleosid
analog
eg
adefovir
pxhnc
moieti
addit
previous
obtain
seri
xch
ch
ch
ch
ch
ch
ch
och
ch
nucleotid
analog
contain
hydroxyalkyl
linker
xch
oh
ch
ch
oh
ch
ch
ch
ch
oh
ch
synthes
coupl
respect
nucleobasederiv
acet
acid
accomplish
good
yield
applic
edc
phosphonatenucleobas
linker
synthes
analog
contain
two
fragment
restrict
rotat
name
amid
bond
pch
oh
ch
n
compound
pch
oh
ch
c
compound
pch
ch
oh
c
compound
residu
judg
h
c
nmr
spectral
data
antiperiplanar
disposit
p
nc
atom
result
steric
bulki
odiethyl
phosphoryl
group
intramolecular
hbond
phosphon
subject
antivir
assay
wide
varieti
dna
rna
virus
appear
inact
concentr
cytostat
properti
evalu
cancer
cell
line
phosphon
show
moder
activ
toward
myeloid
leukemia
ic
multipl
myeloma
cell
ic
respect
studi
analog
phosphon
contain
function
amino
group
within
linker
current
way
laboratori
h
nmr
spectra
record
cd
od
cdcl
follow
spectromet
varian
gemini
mhz
bruker
avanc
iii
mhz
tm
intern
standard
c
nmr
spectra
record
cd
od
cdcl
solut
bruker
avanc
iii
mhz
p
nmr
spectra
perform
varian
gemini
mhz
bruker
avanc
iii
mhz
ir
spectral
data
measur
bruker
alphat
ftir
spectromet
melt
point
determin
boetiu
apparatu
element
analys
perform
microanalyt
laboratori
faculti
perkin
elmer
pe
chn
analyz
result
found
good
agreement
calcul
valu
follow
absorb
use
column
chromatographi
merck
silica
gel
mesh
analyt
tlc
merck
tlc
plastic
sheet
silica
gel
f
tlc
plate
develop
chloroformmethanol
solvent
system
visual
spot
effect
iodin
vapor
solvent
purifi
method
describ
literatur
diethyl
well
protect
aldehyd
diethyl
prepar
accord
literatur
procedur
mixtur
g
epoxid
mmol
cm
dibenzylamin
mmol
heat
h
cool
crude
product
purifi
silica
gel
column
chloroform
give
pure
diethyl
n
ndibenzylamino
g
yield
next
step
solut
g
diethyl
n
ndibenzylamino
mmol
cm
ethanol
hydrogen
mg
pdc
room
temperatur
h
catalyst
remov
layer
celit
solut
concentr
vacuo
afford
pure
phosphon
g
yellowish
oil
mixtur
g
protect
aldehyd
mmol
cm
diethyl
phosphit
mmol
cm
triethylamin
mmol
stir
room
temperatur
h
solut
concentr
vacuo
residu
chromatograph
silica
gel
column
chloroformmethanol
mixtur
vv
give
phosphon
g
white
powder
next
step
solut
g
phosphon
mmol
cm
ethanol
hydrogen
mg
pdc
room
temperatur
h
suspens
filter
pad
celit
wash
ethanol
solut
concentr
vacuo
afford
pure
g
yellowish
oil
solut
aminophosphon
mmol
cm
dmf
chloroform
respect
acet
acid
mmol
edc
hcl
mmol
tea
mmol
ad
reaction
mixtur
stir
room
temperatur
h
concentr
vacuo
residu
chromatograph
silica
gel
column
chloroformmethanol
mixtur
crystal
appropri
solvent
yl
c
e
h
r
ox
e
h
l
p
h
p
h
n
e
accord
gener
procedur
g
diethyl
mmol
g
acet
acid
mmol
amid
g
yield
obtain
white
powder
purif
silica
gel
column
chloroformmethanol
mixtur
accord
gener
procedur
g
diethyl
mmol
g
acet
acid
mmol
amid
g
yield
obtain
white
powder
purif
silica
gel
column
chloroformmethanol
mixtur
accord
gener
procedur
g
diethyl
mmol
g
acet
acid
mmol
amid
g
yield
obtain
white
solid
purif
silica
gel
column
chloroformmethanol
mixtur
accord
gener
procedur
g
diethyl
mmol
g
acet
acid
mmol
amid
g
yield
obtain
white
powder
purif
silica
gel
column
chloroformmethanol
mixtur
accord
gener
procedur
g
diethyl
mmol
g
acet
acid
mmol
amid
g
yield
obtain
white
powder
purif
silica
gel
column
chloroformmethanol
mixtur
vv
hplc
column
accord
gener
procedur
g
diethyl
mmol
g
acet
acid
mmol
amid
g
yield
obtain
white
solid
purif
silica
gel
column
chloroformmethanol
mixtur
accord
gener
procedur
g
diethyl
mmol
g
acet
acid
mmol
pure
amid
accord
gener
procedur
g
diethyl
mmol
g
acet
acid
mmol
amid
g
yield
obtain
white
powder
purif
silica
gel
column
chloroformmethanol
mixtur
vv
crystal
ethanoldiethyl
accord
gener
procedur
g
diethyl
mmol
g
bi
tertbutoxycarbonyl
amino
acet
acid
mmol
crude
product
contamin
triethylamin
hydrochlorid
g
obtain
colorless
oil
purif
silica
gel
column
chloroformmethanol
mixtur
vv
purif
hplc
watermethanol
gave
pure
g
compound
evalu
differ
herp
virus
includ
herp
simplex
viru
type
strain
ko
thymidin
kinasedefici
tk
ko
strain
resist
acv
acv
r
herp
simplex
viru
type
strain
g
varicellazost
viru
vzv
strain
oka
tk
vzv
strain
human
cytomegaloviru
hcmv
strain
davi
well
vaccinia
viru
adeno
human
coronaviru
viru
sindbi
viru
coxsacki
viru
punta
toro
viru
respiratori
syncyti
viru
rsv
influenza
viru
subtyp
influenza
b
viru
base
inhibit
virusinduc
cytopath
plaqu
format
human
embryon
lung
hel
fibroblast
african
green
monkey
kidney
cell
vero
human
epitheli
cervix
carcinoma
cell
hela
madin
darbi
canin
kidney
cell
mdck
confluent
cell
cultur
microtit
plate
inocul
ccid
viru
ccid
viru
dose
infect
cell
cultur
plaqu
form
unit
pfu
cell
cultur
incub
presenc
vari
concentr
test
compound
viral
cytopath
plaqu
format
vzv
record
soon
reach
complet
control
virusinfect
cell
cultur
treat
test
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
virusinduc
cytopath
viral
plaqu
format
cytotox
test
compound
express
minimum
cytotox
concentr
mcc
compound
concentr
caus
microscop
detect
alter
cell
morpholog
assay
perform
microtit
plate
well
ad
tumor
cell
given
amount
test
compound
cell
allow
prolifer
humidifi
co
control
atmospher
end
incub
period
cell
count
coulter
counter
ic
inhibitori
concentr
defin
concentr
compound
inhibit
cell
prolifer
